...medullary thyroid cancer reveals 536 dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clin 537 Endocrinol Metab 98 E364-369. 538
Ahn S, Kim TH, Kim SW, Ki CS, Jang HW, Kim JS, Kim JH, Choe JH, Shin JH, Hahn SY, et 539 al. 2017 Comprehensive screening
for PD-L1 expression in thyr ~~~